# GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

> **NCT00376272** · PHASE3 · COMPLETED · sponsor: **Gruppo di Ricerca GISSI** · enrollment: 1442 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Valsartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00376272
- **Lead sponsor:** Gruppo di Ricerca GISSI
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-03
- **Target enrollment:** 1442 (ACTUAL)
- **Last updated:** 2009-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376272, "GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00376272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*